Cite
Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation
MLA
Doaa A. Helal, et al. “Non-Ionic Surfactant Based Vesicular Drug Delivery System for Topical Delivery of Caffeine for Treatment of Cellulite: Design, Formulation, Characterization, Histological Anti-Cellulite Activity, and Pharmacokinetic Evaluation.” Drug Development and Industrial Pharmacy, vol. 44, no. 1, Sept. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e60e4b861d40f53c78e7c0de60667cc&authtype=sso&custid=ns315887.
APA
Doaa A. Helal, Mohamed A. El-Nabarawi, Sally A. Abdel-Halim, Dalia A. Attia, & Mahmoud H. Teaima. (2017). Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation. Drug Development and Industrial Pharmacy, 44(1).
Chicago
Doaa A. Helal, Mohamed A. El-Nabarawi, Sally A. Abdel-Halim, Dalia A. Attia, and Mahmoud H. Teaima. 2017. “Non-Ionic Surfactant Based Vesicular Drug Delivery System for Topical Delivery of Caffeine for Treatment of Cellulite: Design, Formulation, Characterization, Histological Anti-Cellulite Activity, and Pharmacokinetic Evaluation.” Drug Development and Industrial Pharmacy 44 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e60e4b861d40f53c78e7c0de60667cc&authtype=sso&custid=ns315887.